Day 1: Wednesday, September 23
Day 1: Wednesday, September 23
07:30 - 08:3060 mins
Morning Registration & Breakfast
08:30 - 08:355 mins
KEYNOTE PLENARY
Obesity Science & Innovation Welcome
- Kaitlin Dailey - Senior Conference Producer, Obesity Science & Innovation, Informa Connect
08:35 - 08:5015 mins
KEYNOTE PLENARY
Keynote Opening Address
08:50 - 09:3040 mins
KEYNOTE PLENARY
Keynote Panel: Redefining Healthy Weight-Loss: Innovations, Challenges, and Future Opportunities
- Zealand Pharma, Zealand Pharma
- Steffen-Sebastian Bolz - CSO, Aphaia Pharma AG
- Raj Reddy - CEO, Canary Cure
- Philip Larsen - CEO, Antag Therapeutics
09:30 - 10:1040 mins
KEYNOTE PLENARY
Keynote Panel: Partnerships In Focus - Essential Pharma and Investor “Must Haves”
- Robrecht Thoonen - Senior Director External Innovation, Diabetes, Obesity & Cardiometabolic, Eli Lilly
- Laura Holberger - Associate Director, R&D External Innovation Partners, Novo Nordisk
10:10 - 10:4030 mins
Morning Refreshment Break
10:40 - 11:1030 mins
IN FOCUS: RNA-BASED THERAPIES
Leveraging siRNA Therapeutics to Target the Endocannabinoid and Energy Expenditure Systems for Sustainable Weight Loss and Rare Pediatric Obesity Solutions
- Raj Reddy - CEO, Canary Cure
11:10 - 11:4030 mins
IN FOCUS: RNA-BASED THERAPIES
Resetting gene networks with novel siRNA to treat obesity and T2D
- Janine Sengstack - CSO, Junevity
11:40 - 11:5515 mins
IN FOCUS: RNA-BASED THERAPIES
Spotlight Presentation Opportunity Available
11:55 - 12:2530 mins
IN FOCUS: RNA-BASED THERAPIES
Harnessing srRNA Vectors for Enhanced Protein Expression - Updates From Autoimmune and Metabolic Programs
12:25 - 13:4075 mins
Lunch Break
13:40 - 14:1030 mins
CLINCAL INSIGHTS INCRETIN-BASED THERAPIES
Amylin Pharmacology - Enhancing Patient Experience
- Zealand Pharma, Zealand Pharma
14:10 - 14:4030 mins
CLINCAL INSIGHTS INCRETIN-BASED THERAPIES
NA-931: A Quadruple Receptor Agonist for Weight Loss Therapy Without Muscle Loss
- Lloyd Tran - CEO, Biomed Industries
14:40 - 14:5515 mins
CLINCAL INSIGHTS INCRETIN-BASED THERAPIES
Spotlight Presentation Opportunity Available
14:55 - 15:2530 mins
CLINCAL INSIGHTS INCRETIN-BASED THERAPIES
Progressing A Small Molecule THR-β Agonist, ECC4703, For MASH & Weight Management
15:25 - 15:5530 mins
Afternoon Refreshment Break
15:55 - 16:2530 mins
SPOTLIGHT: PEDRIATRIC & ADOLESCENT OBESITY
Therapeutics for Pediatric & Adolescent Obesity: A Clinicians Perspective Current Gaps and Future Opportunity
- Sonali Malhorta - Director, Obesity, AstraZeneca
16:25 - 16:5530 mins
IN FOCUS: ADIPOSE-TARGETED THERAPIES
Unlocking Brown Adipose Stem Cell Differentiation with a Once-daily Small Molecule
- Olivier Boss - Chief Scientific Officer and Founder, Energesis Pharmaceuticals
16:55 - 17:1015 mins
IN FOCUS: ADIPOSE-TARGETED THERAPIES
Spotlight Presentation Opportunity Available
17:10 - 17:4030 mins
IN FOCUS: ADIPOSE-TARGETED THERAPIES
Presentation: Promoting Localized Mitochondrial Biogenesis Via Notch-inhibiting PLGA Nanoparticles
17:40 - 19:1090 mins
Networking Drinks Reception
19:10 - 19:155 mins
Close of Day 1
* 不測の事態により、事前の予告なしにプログラムが変更される場合があります。